Title | Endocrinology of Breast Cancer [electronic resource] / edited by Andrea Manni |
---|---|
Imprint | Totowa, NJ : Humana Press : Imprint: Humana Press, 1999 |
Connect to | http://dx.doi.org/10.1007/978-1-59259-699-7 |
Descript | X, 392 p. online resource |
I Hormonal Control of Mammary Development and Growth -- 1 Hormonal Control of Normal Breast Morphology and Function -- 2 Interactions Between Estradiol and Progesterone in Normal Breast: Implications for Mammary Carcinogenesis -- 3 Expression and Regulation of Insulin-like Growth Factors and Their Binding Proteins in the Normal Breast -- II Carcinogenesis -- 4 Estrogens and Breast Cancer: An Epidemiologic Perspective -- 5 Androgens, Estrogens, and Breast Cancer Risk -- 6 Local Estrogen Production: Is Aromatase An Oncogene? -- 7 Oncogenes and Mammary Carcinogenesis -- 8 Categorization of Breast Cyst Fluid and Breast Cancer Risk -- III Tumor Progression -- 9 The Role of Tumor Suppressor Genes in Breast Cancer Progression -- 10 Oncogene Activation and Breast Cancer Progression -- 11 Interactions Between Stroma and Epithelium in Breast Cancer: Implications for Tumor Genesis, Growth, and Progression -- 12 The Role of Angiogenesis in the Transition to Hormone Independence and Acquisition of the Metastatic Phenotype -- 13 Role of the IGF System in Breast Cancer Proliferation and Progression -- 14 Prognostic and Predictive Factors in Breast Cancer -- 15 Role of the Polyamine Pathway in the Natural History of Breast Cancer -- IV Estrogen, Progestins, and Prolactin in Breast Cancer Biology: Targets for Treatment -- 16 Aromatase Inhibitors in Breast Carcinoma -- 17 Role of Progestins and Progesterone Receptors in Breast Cancer Biology -- 18 Prolactin and its Receptors in Human Breast Cancer -- V Endocrine Therapy of Breast Cancer -- 19 Pharmacology and Use of Antiestrogens in Treatment and Chemoprevention of Breast Cancer -- 20 LHRH Superagonists and Antagonists in the Treatment of Breast Cancer -- VI Benign Breast Disease -- 21 Benign Breast Lesions: Pathologic Classification and Risk Potential -- 22 Hormonal Treatment of Fibrocystic Disease -- 23 Gynecomastia and Galactorrhea